Highlights Access Pharmaceuticals, Inc. OTC Bulletin Board
Equities
ACCP
US00431M3088
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 30 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
May. 16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |